NCT00407719View on ClinicalTrials.gov

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2008

Conditions
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Interventions
DRUG

Bevacizumab

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT00407719 - Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) | Biotech Hunter | Biotech Hunter